Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
114.24
-0.78 (-0.68%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Revvity Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Revenue Revenue Growth | 2,912 | 2,856 | 2,755 | 2,751 | 3,312 | 3,828 |
Revenue Growth | 4.05% | 3.67% | 0.16% | -16.95% | -13.48% | 43.73% |
Gross Profit Gross Profit Growth | 1,914 | 1,564 | 1,538 | 1,540 | 1,990 | 2,434 |
Operating Income Operating Income Growth | 358.85 | 356.64 | 346.74 | 300.56 | 742.7 | 1,258 |
Net Income Net Income Growth | 237.55 | 241.2 | 270.39 | 693.09 | 569.18 | 943.16 |
Earnings Per Share EPS Growth | 2.10 | 2.07 | 2.20 | 5.55 | 4.50 | 7.62 |
EPS Growth | -9.09% | -5.91% | -60.36% | 23.33% | -40.95% | 134.82% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Life Sciences Life Sciences Growth | 1,445 | 1,431 | 1,399 | 1,458 | 1,293 | 895.87 |
Total Diagnostics Total Diagnostics Growth | 1,466 | 1,425 | 1,356 | 1,292 | 2,019 | 2,932 |
Revenue (Total) Revenue (Total) Growth | 2,912 | 2,856 | 2,755 | 2,751 | 3,312 | 3,828 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Cash & Investments Cash & Investments Growth | 1,023 | 919.86 | 1,163 | 1,603 | 454.36 | 603.32 |
Total Debt Total Debt Growth | 3,342 | 3,368 | 3,302 | 4,032 | 4,564 | 5,131 |
Net Cash (Debt) Net Cash Growth | -2,319 | -2,448 | -2,139 | -2,429 | -4,110 | -4,528 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -20.51 | -21.00 | -17.41 | -19.46 | -32.51 | -38.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 627.63 | 582.93 | 628.3 | 91.27 | 679.81 | 1,411 |
Capital Expenditures CapEx Growth | -69.52 | -73.52 | -86.65 | -81.37 | -85.63 | -86.02 |
Free Cash Flow Free Cash Flow Growth | 558.11 | 509.41 | 541.65 | 9.9 | 594.18 | 1,325 |
Free Cash Flow Growth | 10.96% | -5.95% | 5369.01% | -98.33% | -55.15% | 59.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 5, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Gross Margin | 65.72% | 54.77% | 55.81% | 55.98% | 60.08% | 63.59% |
Operating Margin | 12.32% | 12.49% | 12.59% | 10.93% | 22.43% | 32.88% |
Pretax Margin | 8.96% | 9.39% | 11.47% | 6.65% | 19.68% | 31.44% |
Profit Margin | 8.15% | 8.40% | 10.27% | 6.53% | 15.48% | 23.24% |
FCF Margin | 19.17% | 17.84% | 19.66% | 0.36% | 17.94% | 34.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.280 | 0.280 | 0.280 | 0.280 | 0.280 | 0.280 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.25% | 0.29% | 0.25% | 0.26% | 0.00% | 0.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
PE Ratio | 54.58 | 46.74 | 50.90 | 19.70 | 31.16 | 26.39 |
Forward PE | 20.22 | 18.36 | 22.42 | 24.28 | 24.27 | 29.38 |
P/FCF Ratio | 22.84 | 21.33 | 24.94 | 1362.25 | 29.81 | 38.32 |
PS Ratio | 4.38 | 3.80 | 4.90 | 4.91 | 5.35 | 13.26 |